Respectfully there is a big difference between the last "run" which was based upon the Anti drug abuse technology of the Sequestox formulation and today's corporation which has actual sales and R&D for new high revenue ANDAs. Apparently NH has decided that if you can't beat them, join them; hence the decision to now try to manufacture opioid generics and specifically Oxycontin.
Ironically, if Purdue loses its case against Elite and Elite gets FDA approval for OXY, a bidding war to purchase Elite is likely to occur.
Many here have missed the anniversary and/or got bagged when they didn't take money off the table before SequestOx failed. So congratulations.
News 
Market Data 
Discover 
